Publication Name	World Journal of Clinical Cases
Manuscript ID	78500
Country	Türkiye

Received	2022-06-29 21:23
Peer-Review Started	2022-06-29 21:27
To Make the First Decision
Return for Revision	2022-08-02 22:06
Revised	2022-08-19 15:49
Second Decision	2022-09-26 03:20
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-09-27 01:01
Articles in Press	2022-09-27 01:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-10-17 14:06
Publish the Manuscript Online	2022-10-27 04:55

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Endocrine disruptor chemicals as obesogen and diabetogen: Clinical and mechanistic evidence
Manuscript Source	Invited Manuscript
All Author List	Niyazi Emre Kurşunoğlu and Banu Pinar Sarer Yurekli
ORCID	Author(s) ORCID Number Niyazi Emre Kurşunoğlu http://orcid.org/0000-0001-8089-6000 Banu Pinar Sarer Yurekli http://orcid.org/0000-0003-1809-2655
Funding Agency and Grant Number
Corresponding Author	Banu Pinar Sarer Yurekli, MD, Associate Professor, Department of Endocrinology, Ege University School of Medicine, Ankara Street Bornova, İzmir 35100, Türkiye. bsareryurekli@yahoo.com
Key Words	Endocrine disruptors; Adipogenesis; Obesity; Diabetes mellitus
Core Tip	An exogenous chemical, or mixture of chemicals, that interferes with any aspect of hormone action was defined as Endocrine-Disrupting Chemicals (EDCs). Obesogens can promote obesity by increasing the number of adipocytes and fat storage in existing adipocytes, changing the calories burned at rest, changing the energy balance, and finally regulating satiety. Besides the obesogenic effect, EDCs can cause type 2 diabetes mellitus through alteration in ß cell function and morphology and insulin resistance. In this review, we provide clinical and mechanistic evidence regarding EDCs as obesogen and diabetogen.
Publish Date	2022-10-27 04:55
Citation	Kurşunoğlu NE, Sarer Yurekli BP. Endocrine disruptor chemicals as obesogen and diabetogen: Clinical and mechanistic evidence. World J Clin Cases 2022; 10(31): 11226-11239
URL	https://www.wjgnet.com/2307-8960/full/v10/i31/11226.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i31.11226

Full Article (PDF)	WJCC-10-11226.pdf
Full Article (Word)	WJCC-10-11226.docx
Manuscript File	78500_Auto_Edited-JLW.docx
Answering Reviewers	78500-Answering reviewers.pdf
Audio Core Tip	78500-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	78500-Conflict-of-interest statement.pdf
Copyright License Agreement	78500-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	78500-Language certificate.pdf
Peer-review Report	78500-Peer-review(s).pdf
Scientific Misconduct Check	78500-Bing-Chen YL-2.png
Scientific Editor Work List	78500-Scientific editor work list.pdf